Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 97 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/15/25
End: 09/30/30
Due: 09/30/31
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 05/30/20
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 11/02/20
End: 01/01/27
Due: 01/01/28
Phase: N/A
Priority: Normal
Start: 10/01/14
End: 03/16/20
Due: 03/16/21
Phase: N/A
Priority: Normal
Start: 03/28/18
End: 03/31/20
Due: 03/31/21
Phase: N/A
Priority: Normal
Start: 05/14/24
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 03/15/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 10/02/18
End: 12/20/20
Due: 12/20/21
Phase: N/A
Priority: Normal
Start: 07/25/22
End: 01/30/27
Due: 01/30/28
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 04/25/19
Due: 04/25/20
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 03/01/19
Due: 03/01/20
Phase: N/A
Priority: Normal
Start: 06/11/18
End: 02/28/29
Due: 02/28/30
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 08/25/16
End: 01/25/19
Due: 01/25/20
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 01/04/21
Due: 01/04/22
Phase: N/A
Priority: Normal
Start: 11/09/21
End: 07/27/22
Due: 07/27/23
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 08/01/28
Due: 08/01/29
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 04/03/24
End: 07/31/25
Due: 07/31/26